+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 40Years
All Genders
ID06550102

Study of Drug Response Profiling for Personalized Treatment in Blood Cancers in Patients Up to 40 Years Old

Led by University Children's Hospital, Zurich · Updated on 2024-08-15

1000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating drug response profiling DRP in children and adults under 40 with blood cancers such as leukemia, myeloma, or lymphoma. This observational study aims to evaluate the feasibility of real-time drug sensitivity testing on patient cancer cells to help identify personalized treatment options, especially for patients with refractory disease. The research integrates drug response data with genetic information to better understand cancer dependencies. The study analyzes primary cancer cells taken during routine diagnostics. These cells are grown with supporting cells and exposed to various drugs, including conventional chemotherapies and targeted agents. Automated microscopy captures detailed cell images, which are analyzed to measure drug effects on cell viability. Drug responses are then compared to clinical outcomes and genetic markers to assess their relevance for treatment decisions. Participants contribute tumor samples and clinical data, which are combined with laboratory tests measuring drug sensitivity and genetic features. Researchers track responses to treatments over time, including minimal residual disease assessments. The main outcome is determining whether real-time drug profiling can be performed within 10 days. The study also monitors how this data can be translated to clinical care over one month, involving collaboration with international leukemia research networks.

CONDITIONS

Brief Title

Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

Research Team

J

Jean-Pierre Bourquin, MD, PhD

F

Fabio Steffen, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here